Home
Join EHTG
Login
RSS Feed
Twitter
About Us
EHTG Meeting 2021
Welcome
Programme Overview
Register Your Interest
Other Events
Past Meetings
4th Meeting 2019
3rd Meeting 2018
2nd Meeting 2017
1st Meeting 2016
Collaborative Studies
The Prospective Lynch Syndrome Database
Guidelines
Publications
Membership
Home
>
Past meetings
>
3rd Meeting 2018
>
Programme
>
Working Group – Clinical
Working Group – Clinical
Date
: Monday 24 September 2018
Time
: 09:00 – 12:30
Time
Session
09:00 – 10:30
Clinical Abstracts
(8 mins for presentation + 2 mins for questions)
Chairs
: Laura Renkonen-Sinisalo (Finland), Ingrid Winship (Australia)
09:00 – 09:10
N35: An assessment of endometrial cancer risk markers in lynch syndrome patients – Angel Alonso Sanchez (Spain)
09:10 – 09:20
N81:Genomic and transcriptomic profiling of duodenal adenomas in familial adenomatous (FAP) and MUTYH-associated polyposis (MAP) – Elena Meuser (UK)
09:20 – 09:30
The phenotype of POLE and POLD1 – Ingrid Winship (Australia)
09:30 – 09:40
N87:SELINA – clinical trial on lowering the risk of malignancies by optimizing selenium levels in females from families with hereditary breast cancer – Jan Lubinski (Poland)
09:40 – 09:50
N38:Yield of Lynch syndrome surveillance for individual MMR genes – Anja Wagner (The Netherlands)
09:50 – 10:00
N43:Hide and seek with hereditary cancer: testing the effectiveness and cost-effectiveness of implementation approaches for translating Lynch Syndrome evidence into practice – Natalie Taylor (Australia)
10:00 – 10:10
N83:Surveillance recommendations for first-degree relatives of patients with unexplained multiple colorectal adenomas: a nationwide survey of UK regional genetic services -Bianca Desouza (UK)
10:10 – 10:20
N58:The cost of identifying Lynch syndrome carriers in Australia – Mary Dillon (Finland)
10:20 – 10:30
N11:A dominantly inherited 5’UTR variant causing methylation associated silencing of BRCA1 as a novel cause of breast and ovarian cancer – Gareth D. Evans (UK)
10:30 – 11:00
Coffee break
Chairs
: Gareth D. Evans (UK), Zohar Levi (Israel)
11:00 – 11:20
N27:The management of gynaecological cancers in Lynch syndrome: the Manchester International Consensus Meeting – Emma Crosbie (UK)
11:20 – 11:40
N42: Improving triaging of patients with sebaceous neoplasiaa for the identification of Muir-Torre/Lynch syndrome – Ingrid Winship (Australia)
11:40 – 12:00
N67:Penetrance for carriers of a DNA mismatch repair gene specific variant – Aung Ko Win (Australia)
12:00 – 12:30
Hi-speed abstract presentations
(3 mins for presentation + 2 mins for questions)
12:00 – 12:05
N47:Prevalence of mismatch repair deficiency in small bowel carcinomas and neuroendocrine tumours – Manon Suerink (The Netherlands)
12:05 – 12:10
N84:Mutations in MutYH gene among Russian patients with colorectal polyps – Alex Tsukanov (Russian Federation)
12:10 – 12:15
N63:Clinical and molecular characterization of Lynch-like syndrome -Maria Dolores Picó (Spain)
12:15 – 12:20
N61:Physical activity and the risk of colorectal cancer in Lynch syndrome – S Ghazaleh Dashti (Australia)
12:20 – 12:25
N68:A multidisciplinary approach to familial pancreatic cancer enriches the proportion of patients with pancreatic cancer susceptibility -Giulia Martina Cavestro (Italy)
12:25 – 12:30
N05:Exogenous and endogenous associated factors to early onset colorectal cancer -Raffaella Alessia Zuppardo (Italy)
Past Meetings
4th Meeting 2019
Overview
Programme
(wh)y-EHTG Plenary Session
Missing the Target Plenary
Microbiome
Gynaecology
Genetics and Gene Panel Testing
Immunology and Pathology
Dermatology and Urology
Genetic Counselling
MMR / Variant Interpretation
Gastroenterology
Polyposis Syndromes
Clinical Management and Guidance
Collaborative Studies
Registries
Chemoprevention
Working Groups Reporting Back
Joint AsCAP/EHTG Therapeutic Prevention Session
State of the Art Lectures
Speakers and Faculty
3rd Meeting 2018
Programme
State of the Art Lectures
Working Group – Clinical
Working Group – EHTG Living Guidance
Working Group – European MMR Group
Working Group – Gastroenterology
Working Group – Gene Panel
Working Group – Genetics
Working Group – Pathology and Immunology
Working Group – Registries
Working Group – Surgery
Speakers and Faculty
Abstracts
2nd Meeting 2017
1st Meeting 2016
Programme
Thursday: Working Groups
Registries and Biobanks
MMR European Group
Surgery and Endoscopy
Chemoprevention for Polyposis Syndromes Workshop
VIC: Variant Interpretation Committee
Chemoprevention and Immunotherapy Workshop
Friday: Plenary Scientific Meeting
Saturday: Collaborative
Speakers
Abstracts
Organising Committee
Contact Information
European Hereditary Tumour Group Secretariat
0131 656 5635
Email
c/o Lindsays, Caledonian Exchange, 19A Canning Street, Edinburgh EH3 8HE, UK
Top